ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 711

1,25(OH)2D3 Inhibits Th17 Cytokine Production and RORγt Expression Through GATA3/IL4-Dependent and -Independent Mechanisms

Wendy Dankers1, Jan Piet van Hamburg2,3, Anne-Marie Mus1, Patrick S. Asmawidjaja1, Johannes van Leeuwen4, Rudi W. Hendriks5, Louis Boon6, Edgar Colin7 and Erik Lubberts1,8, 1Rheumatology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 2Rheumatology, Erasmus MC, Rotterdam, Netherlands, 3Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 5Pulmonary Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 6Bioceros, Utrecht, Netherlands, 7Department of Rheumatology, ZGT, Almelo, Netherlands, 8Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: interleukins (IL) and rheumatoid arthritis (RA), T cells, Vitamin D

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease: Signaling Pathways in T-cell Differentiation

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Vitamin D has suppressive effects on autoimmune diseases, such as rheumatoid arthritis (RA). One important mechanism of disease suppression by vitamin D is inhibition of Th17 cytokines and the Th17 transcription factor RORγt. On the other hand, vitamin D induces IL-4 and GATA3. Since GATA3 overexpression inhibits experimental Th17-mediated autoimmunity, we studied the contribution of GATA3 in vitamin D-mediated suppression of Th17 polarization.

Methods:

We first sorted CD4+ T cells from the spleen of naïve DBA-1 mice and DBA-1 mice immunized with collagen type II (CII) and cultured them under T helper cell polarizing conditions with or without 1,25(OH)2D3, the active form of vitamin D. Furthermore, splenic CD4+ T cells are sorted from wild-type and CD2-GATA3 transgenic mice and cultured under these conditions. Finally, we performed gene-expression profiling on CCR6+cells from treatment-naïve early RA patients.

Results:

In cultures of CD4+ T cells from naïve and CII-immunized mice, 1,25(OH)2D3 inhibits Th17 polarization while inducing IL-4 and GATA3 expression. IL-4 inhibition partly reversed the vitamin D-mediated inhibition of Th17 polarization. To study the role of GATA3, we compared CD4+ T cells from wild-type and CD2-GATA3 transgenic mice after culture under Th17 polarizing conditions. In these cultures 1,25(OH)2D3 reduces Th17 differentiation, but the effect of GATA3 overexpression is stronger. Interestingly, combining GATA3 overexpression and 1,25(OH)2D3 treatment reduced IL-17A and RORγt expression even further. Subsequent analysis of gene expression in wild-type CD4+ T cells cultured under Th17 polarizing conditions showed that NFAT-C2, which is involved in IL-17A production, was downregulated by 1,25(OH)2D3. In addition, gene expression analysis in CCR6+ T cells from patients with RA showed that 1,25(OH)2D3also inhibits Th17 cytokine and RORγt expression in humans, while inducing IL-4 and GATA3 expression.

Conclusion:

These data show that vitamin D-mediated regulation of Th17 polarization occurs through GATA3-dependent mechanisms, including direct effects on RORγt expression and IL-4-mediated inhibition of Th17 polarization. Moreover, GATA3-independent mechanisms are involved that may include modulation of NFAT-C2. These mechanisms may play a role in the suppressive effect of vitamin D on RA disease activity.


Disclosure:

W. Dankers,
None;

J. P. van Hamburg,
None;

A. M. Mus,
None;

P. S. Asmawidjaja,
None;

J. van Leeuwen,
None;

R. W. Hendriks,
None;

L. Boon,
None;

E. Colin,
None;

E. Lubberts,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/125oh2d3-inhibits-th17-cytokine-production-and-ror%ce%b3t-expression-through-gata3il4-dependent-and-independent-mechanisms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology